Lockdown Led to 70% Drop in NYC COVID Spread, Masks Also Effective

Newswise — Reducing contact rates—mainly via school closures and voluntary or mandated stay-at-home measures—contributed to around a 70 percent reduction in the transmission of COVID-19 in New York City during the spring pandemic wave from March to the June reopening. Widespread use of face coverings contributed an additional 7 percent reduction, and up to 20 percent reduction among those aged 65 and older during the first month face covering was mandated in public places.

The study by scientists at Columbia University Mailman School of Public Health and the New York City Department of Health and Mental Hygiene appears ahead of peer review in the preprint server medRxiv.

The new study is in line with previous modeling studies estimating that lockdowns reduced COVID-19 transmission by 58 percent in Wuhan, China, 45 percent in Italy, and 77 in France.

The New York City study finds reducing contact rates was highly effective for most age groups—contributing to at least a 50 percent reduction in transmission across age groups, ranging from a 51 percent reduction among 1-4 year-olds to 83 percent among 5-14 year-olds.

Face Coverings Are Key to a Safer Reopening

If the city maintained the same usage rates of face coverings in April into the reopening period starting June 8, the researchers estimate that face coverings would reduce overall COVID-19 transmission by approximately 9–11 percent during reopening when people spend a greater amount of time outside homes and use face coverings outside. However, if everyone wore masks in the same degree and manner as older adults, the city could reduce overall transmission by as much as 28–32 percent.

The researchers note their estimates differ from those measuring how effective face coverings can prevent COVID-19 infection when used correctly. Rather, estimates reflect the effectiveness of face coverings and the impact of this public health intervention in reducing transmission at the population level, which also depends on the usage rate of face coverings, whether face coverings are properly used, the amount of time face coverings are used, in addition to mask efficacy. Observational studies and surveys report about two-fold high rates of face covering usage among older adults versus younger adults and minors. The researchers estimate much higher effectiveness among older adults (~20% for both 65-74 and 75+ year-olds vs. <10% for other age groups).

“Improving effective use of face coverings, especially among younger people, would significantly mitigate the risk of a resurgence in COVID-19 infections during re-opening,” says senior author Jeffrey Shaman, PhD, professor of environmental health sciences at Columbia Mailman School. “It’s crucial that we find ways to boost consistent and correct mask use in settings where social distancing is not possible.”

“Overall, our study supports the need for multiple interventions, including restricting occupancy to reduce contact rates, universal face covering, testing and contact tracing, and isolation and timing treatment of active infections,” says lead author Wan Yang, PhD, assistant professor of epidemiology at Columbia Mailman School. “We need to implement all of those simultaneously in order to effectively mitigate the spread of COVID-19.” 

Study Methods

The researchers developed a model to simulate the spread of COVID-19 in New York City using city data on cases, deaths, along with mobility data to estimate transmission. They first used mobility data as a proxy for population contact rates to estimate the transmission reduction associated with interventions reducing contact rates, including school closures and the stay-at-home mandate. They then further separated this impact from the overall transmission reduction to estimate the impact of face coverings. The researchers also validated their model estimates based on the accuracy predicting cases and deaths eight weeks beyond the study period.

Background on COVID in New York City

New York City experienced widespread COVID-19 transmission citywide since early March and recorded over 200,000 cases and over 21,000 COVID-19 confirmed or probable deaths during the following three months. New York State and New York City implemented multiple intervention measures, including health promotion campaigns in early March, telecommuting and staggered work schedule recommendations beginning the week of March 8, public schools closure starting the week of March 15, stay-at-home orders for non-essential workers starting the week of March 22, and requirements for use of face covering in public starting the week of April 12. With these overlapping and far reaching public health interventions, case diagnoses and hospitalizations peaked in April, and started to decline substantially in late April and May. The city began its phased re-opening of industries starting the week of June 7.

Co-authors included Wan Yang and Jeffrey Shaman from Columbia Mailman School, and Jaimie Shaff from the New York City Department of Health and Mental Hygiene (NYC DOHMH).

This study was supported by the National Institute of Allergy and Infectious Diseases (AI145883), the National Science Foundation Rapid Response Research Program (RAPID; 2027369), and the NYC DOHMH.

Shaman and Columbia University disclose partial ownership of SK Analytics, a provider of influenza forecasting and analytics services. Shaman discloses consulting for Business Networking International. Other authors have nothing to disclose.

Columbia University Mailman School of Public Health

Columbia University Mailman School of Public Health Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the seventh largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master’s and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity.  For more information, please visit publichealth.columbia.edu.

 




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.08385